BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
And then there's a small group of patients that may need even more that They may need intensification and just monotherapy, immunotherapy is not enough. So I think that's where the role of ctDNA comes in. And I love that there are prospective trials trying to answer that question right now, the Invigor 011.
0
💬
0
Comments
Log in to comment.
There are no comments yet.